Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial.

Saved in:
Bibliographic Details
Title: Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial.
Authors: Tada, Atsushi1, Burkhoff, Daniel2, Naser, Jwan A.1, Tomonari Harada1, Pourmussa, Bianca3, Reddy, Yogesh N. V.1, Jensen, Michael D.4, Carter, Rickey E.5, Demmer, Ryan T.6, Testani, Jeffrey M.7, Chirinos, Julio A.3, Borlaug, Barry A.1
Source: Circulation. 9/24/2024, Vol. 150 Issue 13, p997-1009. 13p.
Database: Academic Search Ultimate
Description
ISSN:00097322
DOI:10.1161/CIRCULATIONAHA.124.068788